A new saliva-based coronavirus test has been approved for holidaymakers, it is reported.
The new test by testing service HALO costs £89 and lets you swab your mouth instead of your nose.
This means Brits wouldn't have to go through the procedure of having a swab in the back of the throat and the nostril.
It is the first saliva-based PCR test to reportedly be given approval for holidaymakers.
HALO Founder Jonathan Biles told the Sun: “With our new Day 2 and 8 test service, we will provide British travellers with a painless, safe, reliable and cost-effective way to approach travel.
“Our new Day 2 and 8 testing service will continue our relentless focus on quality.
"With a test success rate of over 99 per cent, our own first-class lab at Imperial College London and a UK based customer support team operating 24 hours a day seven days a week, we pride ourselves on offering the most complete, best-value testing service available."
The Department of Health and Social Care did not comment when contacted by The Mirror.
This comes as results of a University of Oxford trial show a comprehensive testing system is key to resuming international travel.
The experiment, which involved data from almost 600 travellers on flights from the US to Heathrow, also showed passengers would be happy to pay for their own tests.
Researchers at the Oxford Internet Institute (OII) used flights operated by British Airways and American Airlines for the trial, which took place between November 2020 and March 2021.
Travellers took a PCR test 72 hours before departure, a LAMP test upon arrival at Heathrow - a type which returns results more quickly than the PCR - and a third PCR taken three to five days after returning.
According to the researchers, just one per cent of travellers who took the first PCR tested positive and so did not travel, and none of those who touched down in the US tested positive, suggesting the first test was effective.
Of the travellers who took the third test after arriving in the UK, 0.4% of travellers tested positive.
In a joint statement on the findings, American Airlines, British Airways and oneworld said: "The trial findings underline the important role that testing can play in the safe reopening of international travel, including hugely significant routes between the US and UK."
The airlines said they would be ready to partner with governments to offer affordable testing options, adding the study "further reinforces that customers are willing to undergo testing as an alternative to quarantine".
Some 99.7% of travellers said they were happy to adhere to testing requirements as an alternative to quarantine after international travel and 80% were prepared to pay for affordable testing.
The majority were prepared to pay £35 or less for each test, and 15% said they would pay more than £70.
Findings of the Oxford study will be shared with governments and stakeholders.
Professor Philip Howard, professor of internet studies at the OII, said: "As many countries make progress on vaccinating their citizens the debate over reopening travel safely is becoming increasingly important.
"I'm pleased our team has been able to make a contribution to this discussion through this detailed analysis of passenger sentiment and behaviour."
